Cited by 107Lipoproteins and Cardiovascular HealthClinical practice guidelines implementationCoronary Interventions and Diagnostics

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide

Open access

Pokharel, Yashashwi, Tang, Fengming, Jones, Philip G., Nambi, Vijay, Bittner, Vera A., Hira, Ravi S., Nasir, Khurram, Chan, Paul S., Maddox, Thomas M., Oetgen, William J., Heidenreich, Paul A., Borden, William B., Spertus, John A., Petersen, Laura A., Ballantyne, Christie M., Virani, Salim S.·2017·JAMA Cardiology

DOI 10.1001/jamacardio.2016.5922PMC PMC5470413

Open this paper in CoChat — free account

Abstract

Importance: The 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline recommends moderate-intensity to high-intensity statin therapy in eligible patients. Objective: To examine adoption of the 2013 ACC/AHA guideline in US cardiology practices. Design, Setting, and Participants: Among 161 cardiology practices, trends in the use of moderate-intensity to high-intensity statin and nonstatin lipid-lowering therapy (LLT) were analyzed before (September 1, 2012, to November 1, 2013) and after (February 1, 2014, to April 1, 2015) publication of the 2013 ACC/AHA guideline among 4 mutually exclusive risk groups within the ACC Practice Innovation and Clinical Excellence Registry. Interrupted time series analysis was used to evaluate for differences in trend in use of moderate-intensity to high-intensity statin and nonstatin LLT use in hierarchical logistic regression models. Participants were a population-based sample of 1 105 356 preguideline patients (2 431 192 patient encounters) and 1 116 472 postguideline patients (2 377 219 patient encounters). Approximately 97% of patients had atherosclerotic cardiovascular disease (ASCVD). Exposures: Moderate-intensity to high-intensity statin and nonstatin LLT use before and after publication of the 2013 ACC/AHA guideline. Main Outcomes and Measures: Time trend in the use of moderate-intensity to high-intensity statin and nonstatin LLT. Results: In the study cohort, the mean (SD) age was 69.6 (12.1) years among 1 105 356 patients (40.2% female) before publication of the guideline and 70.0 (11.9) years among 1 116 472 patients (39.8% female) after publication of the guideline. Although there was a trend toward increasing use of moderate-intensity to high-intensity statins overall and in the ASCVD cohort, such a trend was already present before publication of the guideline. No significant difference in trend in the use of moderate-intensity to high-intensity statins was observed in other groups. The use of moderate-intensity to high-intensity statin therapy was 62.1% (before publication of the guideline) and 66.6% (after publication of the guideline) in the overall cohort, 62.7% (before publication) and 67.0% (after publication) in the ASCVD cohort, 50.6% (before publication) and 52.3% (after publication) in the cohort with elevated low-density lipoprotein cholesterol levels (ie, ≥190 mg/dL), 52.4% (before publication) and 55.2% (after publication) in the diabetes cohort, and 41.9% (before publication) and 46.9% (after publication) in the remaining group with 10-year ASCVD risk of 7.5% or higher. In hierarchical logistic regression models, there was a significant increase in the use of moderate-intensity to high-intensity statins in the overall cohort (4.8%) and in the ASCVD cohort (4.3%) (P < .01 for slope for both). There was no significant change for other risk cohorts. Nonstatin LLT use remained unchanged in the preguideline and postguideline periods in the hierarchical logistic regression models for all of the risk groups. Conclusions and Relevance: Adoption of the 2013 ACC/AHA Cholesterol Management Guideline in cardiology practices was modest. Timely interventions are needed to improve guideline-concordant practice to reduce the burden of ASCVD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jamacardio.2016.5922

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Crossing the Quality Chasm: A New Health System for the 21st Century
Baker, A. (2001) · BMJ · doi:10.1136/bmj.323.7322.1192 · Cited by 10,779
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.002 · Cited by 3,845
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Use of Interrupted Time Series Analysis in Evaluating Health Care Quality Improvements
Penfold, R. B., & Zhang, F. (2013) · Academic Pediatrics · doi:10.1016/j.acap.2013.08.002 · Cited by 1,150
Application of New Cholesterol Guidelines to a Population-Based Sample
Pencina, M. J., Navar‐Boggan, A. M., D’Agostino, R. B., Williams, K., Neely, B., Sniderman, A. D., & Peterson, E. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315665 · Cited by 612
An Analysis of Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort
DeFilippis, A. P., Young, R. L., Carrubba, C. J., McEvoy, J. W., Budoff, M. J., Blumenthal, R. S., Kronmal, R. A., McClelland, R. L., Nasir, K., & Blaha, M. J. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1281 · Cited by 534
Self-citation

Show all 31 references

Sorted by citations

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
Self-citation
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.003 · Cited by 2,691
Self-citation
Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry
Bradley, C. K., Wang, T. Y., Li, S., Robinson, J. G., Roger, V. L., Goldberg, A. C., Virani, S. S., Louie, M. J., Lee, L. V., Peterson, E. D., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011765 · Cited by 286
Self-citation
Deep convolutional neural networks to predict cardiovascular risk from computed tomography
Zeleznik, R., Foldyna, B., Eslami, P., Weiss, J., Alexander, I., Taron, J., Parmar, C., Alvi, R. M., Banerji, D., Uno, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-20966-2 · Cited by 240
High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S.
Nelson, A. J., Haynes, K., Shambhu, S., Eapen, Z. J., Cziraky, M. J., Nanna, M. G., Calvert, S. B., Gallagher, K., Pagidipati, N. J., & Granger, C. B. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.02.048 · Cited by 157
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
Nissen, S. E., Menon, V., Nicholls, S. J., Brennan, D., Laffin, L., Ridker, P., Ray, K. K., Mason, D., Kastelein, J. J. P., Cho, L., et al. (2023) · JAMA · doi:10.1001/jama.2023.9696 · Cited by 146
Deep Learning to Assess Long-term Mortality From Chest Radiographs
Lu, M. T., Ivanov, A., Mayrhofer, T., Hosny, A., Aerts, H. J. W. L., & Hoffmann, U. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.7416 · Cited by 140
Therapeutic Inertia in Cardiovascular Disease Prevention
Dixon, D. L., Sharma, G. V., Sandesara, P. B., Yang, E., Braun, L. T., Mensah, G. A., Sperling, L. S., DEEDWANIA, P. C., & Virani, S. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.014 · Cited by 105
Self-citation
New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B
Nurmohamed, N. S., Návar, A. M., & Kastelein, J. J. P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.079 · Cited by 116
Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014
Rosenson, R. S., Farkouh, M. E., Mefford, M. T., Bittner, V., Brown, T. M., Taylor, B., Monda, K. L., Zhao, H., Dai, Y., & Muntner, P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.585 · Cited by 84
Self-citation
Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines
Matyori, A., Brown, C., Ali, A. A., & Sherbeny, F. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.04.002 · Cited by 83
Barriers to PCSK9 inhibitor prescriptions for patients with high cardiovascular risk: Results of a healthcare provider survey conducted by the National Lipid Association
Cohen, J. D., Cziraky, M. J., Jacobson, T. A., Maki, K. C., & Karalis, D. G. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.04.120 · Cited by 68
Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322 153 Patients
Návar, A. M., Kolkailah, A. A., Gupta, A., Gillard, K. K., Israel, M. K., Wang, Y., & Peterson, E. D. (2023) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.122.009787 · Cited by 65
Bempedoic Acid (ETC-1002)
Saeed, A., & Ballantyne, C. M. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2017.12.007 · Cited by 51
Self-citation
Trends in U.S. Ambulatory Cardiovascular Care 2013 to 2017
Maddox, T. M., Song, Y., Allen, J. M., Chan, P. S., Khan, A., Lee, J., Mitchell, J. D., Oetgen, W. J., Ponirakis, A., Segawa, C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.011 · Cited by 49
Self-citation
Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended Indication for Primary Prevention of Cardiovascular Disease in Cardiology Practices: Insights From the NCDR PINNACLE Registry
Hira, R. S., GOSCH, K. L., Kazi, D. S., Yeh, R. W., Kataruka, A., Maddox, T. M., Shah, T., Jneid, H. M., Bhatt, D. L., & Virani, S. S. (2022) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.121.007979 · Cited by 48
Self-citation
Trends in Statin Use 2009–2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol
Harrison, T. N., Scott, R. D., Cheetham, T. C., Chang, S., Hsu, J. Y., Wei, R. X., Grant, D. L., Boklage, S., Romo‐LeTourneau, V., & Reynolds, K. (2018) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-6810-1 · Cited by 44
Cardiovascular Disease Risk–Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network
Saeed, A., Zhu, J., Thoma, F. W., Marroquin, O. C., Aiyer, A., Agarwala, A., Virani, S. S., Gulati, M., Lee, J. S., Reís, S. E., et al. (2021) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.007485 · Cited by 39
Self-citation
Intensive versus moderate statin therapy and early graft occlusion after coronary bypass surgery: The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events randomized clinical trial
Kulik, A., Abreu, A. M., Boronat, V., & Ruel, M. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.05.123 · Cited by 40
Association of Primary Care Providers’ Beliefs of Statins for Primary Prevention and Statin Prescription
Clough, J. D., Martin, S. S., Návar, A. M., Lin, L., Hardy, N. C., Rogers, U. A., & Curtis, L. H. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010241 · Cited by 30
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs
Virani, S. S., Akeroyd, J. M., Ahmed, S. T., Krittanawong, C., Martin, L. A., Slagle, J. M., Gobbel, G. T., Matheny, M. E., Ballantyne, C. M., & Petersen, L. A. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.08.002 · Cited by 29
Self-citation
Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007—2015: A Serial, Cross‐sectional Study
Hof, J. V., Duval, S., Walts, A., Kopecky, S. L., Luepker, R. V., & Hirsch, A. T. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006328 · Cited by 26
Improving adherence to cardiovascular guidelines: realistic transition from paper to patient
Mahtta, D., Rodríguez, F., Jneid, H. M., Levine, G. N., & Virani, S. S. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1717335 · Cited by 27
Self-citation
Current trends in non–HDL cholesterol and LDL cholesterol levels in adults with atherosclerotic cardiovascular disease
Vega, G. L., & Grundy, S. M. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.05.012 · Cited by 25
Association of Region and Hospital and Patient Characteristics With Use of High-Intensity Statins After Myocardial Infarction Among Medicare Beneficiaries
Bittner, V., Colantonio, L. D., Dai, Y., Woodward, M., Mefford, M. T., Rosenson, R. S., Muntner, P., Monda, K. L., Kilgore, M. L., Jaeger, B. C., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.2481 · Cited by 25
Self-citation
Prescription of suboptimal statin treatment regimens: a retrospective cohort study of trends and variation in English primary care
Curtis, H. J., Walker, A. J., MacKenna, B., Croker, R., & Goldacre, B. M. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x710873 · Cited by 23
Trends in Discharge Rates for Acute Pulmonary Embolism in U.S. Emergency Departments
Watson, N. W., Carroll, B., Krawisz, A. K., Schmaier, A. A., & Secemsky, E. A. (2024) · Annals of Internal Medicine · doi:10.7326/m23-2442 · Cited by 24
Guidelines for the management of hyperlipidemia: How can clinicians effectively implement them?
Dembowski, E., Freedman, I. G., Grundy, S. M., & Stone, N. J. (2022) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2022.11.009 · Cited by 25
Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery system
Reynolds, K., Mues, K., Harrison, T. N., Qian, L., Chen, S., Hsu, J.-W. Y., Philip, K., Monda, K., Reading, S., & Brar, S. (2019) · Vascular Medicine · doi:10.1177/1358863x19871100 · Cited by 18
Trends in prevalence of guideline‐based use of lipid‐lowering therapy in a large health system
Sidebottom, A. C., Vacquier, M. C., Jensen, J. C., Bradley, S. M., Knickelbine, T., Strauss, C., & Miedema, M. D. (2020) · Clinical Cardiology · doi:10.1002/clc.23347 · Cited by 21
Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-Analysis
Jaam, M. J., Al-Naimi, H., Haddad, M. M., Abushanab, D., & Al‐Badriyeh, D. (2023) · Journal of Comparative Effectiveness Research · doi:10.57264/cer-2022-0163 · Cited by 24
Measurement of Low‐Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry
Lowenstern, A. M., Li, S., Návar, A. M., Roger, V. L., Robinson, J. G., Goldberg, A. C., Virani, S. S., Lee, L. V., Wilson, P. W. F., Louie, M. J., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009251 · Cited by 21
Self-citation
Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States
Baum, S. J., Rane, P., Nunna, S., Habib, M., Philip, K. J., Sun, K., Wang, X., & Wade, R. L. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100177 · Cited by 20
The evaluation and management of patients with LDL-C ≥ 190 mg/dL in a large health care system
Jackson, C. L., Ahmad, Z., Das, S. R., & Khera, A. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100002 · Cited by 19
Recommended and observed statin use among U.S. adults – National Health and Nutrition Examination Survey, 2011-2018
Thompson‐Paul, A. M., Gillespie, C., Wall, H. K., Loustalot, F. V., Sperling, L. S., & Hong, Y. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.12.005 · Cited by 19
Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease—Real-world experience within a large integrated health care system: The IMPRES study
Anderson, J. L., Knowlton, K. U., May, H. T., Bair, T. L., Armstrong, S. O., LAPPE, D. L., & Muhlestein, J. B. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.03.084 · Cited by 17
Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial
Crew, K. D., Bhatkhande, G., Silverman, T. B., Amenta, J. N., Jones, T., McGuinness, J. E., Mata, J. M., Guzman, A., He, T., Dimond, J. P., et al. (2022) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0013 · Cited by 18
Unsung heroes in health education and promotion: How Community Health Workers contribute to hypertension management
Bush, K., Patrick, C., Elliott, K., Morris, M., Tiruneh, Y. M., & McGaha, P. K. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1088236 · Cited by 22
Developing implementation strategies to improve uptake of guideline-recommended treatments for individuals with familial hypercholesterolemia: A protocol
Jones, L. K., Gidding, S. S., Seaton, T., Goldberg, A. C., Gregor, C. M., Sturm, A. C., Brownson, R. C., Rahm, A. K., & Williams, M. S. (2019) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2019.06.006 · Cited by 16
Comparison of High-Dose Rosuvastatin Versus Low-Dose Rosuvastatin Plus Ezetimibe on Carotid Atherosclerotic Plaque Inflammation in Patients with Acute Coronary Syndrome
Oh, M., Kim, H., Shin, E. W., Sung, C., Kim, D., Moon, D. H., Kim, N., Eo, J. S., Kim, J. W., & Lee, C. W. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10009-4 · Cited by 17
Factors affecting statin uptake among people living with HIV: primary care provider perspectives
Ober, A. J., Takada, S., Zajdman, D., Todd, I., Horwich, T. B., Anderson, A., Wali, S., & Ladapo, J. A. (2021) · BMC Family Practice · doi:10.1186/s12875-021-01563-0 · Cited by 15
National trends and disparities in statin use for ischemic heart disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey
Minhas, A. M. K., Ijaz, S. H., Javed, N., Sheikh, A. B., Jain, V., Michos, E. D., Greene, S. J., Fudim, M., Warraich, H. J., Shapiro, M. D., et al. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.05.015 · Cited by 15
Self-citation
Effects of Guideline and Formulary Changes on Statin Prescribing in the Veterans Affairs
Markovitz, A. A., Holleman, R. G., Hofer, T. P., Kerr, E. A., Klamerus, M. L., & Sussman, J. B. (2017) · Health Services Research · doi:10.1111/1475-6773.12788 · Cited by 15
Uptake of Statin Guidelines to Prevent and Treat Cardiovascular Disease
Tong, S. T., Sabo, R., Hochheimer, C. J., Brooks, E. M., Jiang, V., Huffstetler, A. N., Kashiri, P. L., & Krist, A. H. (2021) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2021.01.200292 · Cited by 15
Association Between Poverty and Appropriate Statin Prescription for the Treatment of Hyperlipidemia in the United States: An Analysis From the ACC NCDR PINNACLE Registry
Tanguturi, V. K., Kennedy, K. F., Virani, S. S., Maddox, T. M., Armstrong, K., & Wasfy, J. H. (2020) · Cardiovascular Revascularization Medicine · doi:10.1016/j.carrev.2019.12.026 · Cited by 14
Self-citation
Implications of cost-effectiveness analyses of lipid-lowering therapies: From the policy-maker's desk to the patient's bedside
Kazi, D. S., & Virani, S. S. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.10.006 · Cited by 14
Self-citation
Patterns of statin non-prescription in patients with established coronary artery disease: A report from a contemporary multicenter Japanese PCI registry
Sawano, M., Kohsaka, S., Abe, T., Inohara, T., Maekawa, Y., Ueda, I., Sueyoshi, K., Suzuki, M., Noma, S., Numasawa, Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182687 · Cited by 14
Self-citation
Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline
Bucheit, J. D., Helsing, H., Nadpara, P. A., Virani, S. S., & Dixon, D. L. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.11.010 · Cited by 14
Self-citation
Temporal Trends of High‐Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention
Abdulhak, A. A. B., Vaughan‐Sarrazin, M., Kaboli, P. J., Horwitz, P. A., Mosher, H. J., Sigurðsson, G., Walker, N. E., Wallace, R. B., & Robinson, J. G. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007370 · Cited by 14
Intensive versus moderate atorvastatin therapy and one-year graft patency after CABG: Rationale and design of the ACTIVE (Aggressive Cholesterol Therapy to Inhibit Vein Graft Events) randomized controlled trial (NCT01528709)
Kulik, A., Abreu, A. M., Boronat, V., & Ruel, M. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.06.006 · Cited by 13
Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation
Loring, Z., Shrader, P. J., Allen, L. A., Blanco, R. G., Chan, P. S., Ezekowitz, M. D., Fonarow, G. C., Freeman, J. V., Gersh, B. J., Mahaffey, K. W., et al. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.10.008 · Cited by 13
Self-citation
Point-of-care testing to promote cardiovascular disease risk assessment: A proof of concept study
Karmali, K. N., Brown, T., Sanchez, T., Long, T., & Persell, S. D. (2017) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2017.05.016 · Cited by 12
Statins in Secondary Prevention
Stone, N. J. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.018 · Cited by 12
Impact of lipid levels and high‐intensity statins on vein graft patency after CABG: Midterm results of the ACTIVE trial
Kulik, A., Abreu, A. M., Boronat, V., & Ruel, M. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.15014 · Cited by 11
Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial
Takada, S., Ober, A. J., Currier, J. S., Goldstein, N. J., Horwich, T. B., Mittman, B. S., Shu, S. B., Tseng, C., Vijayan, T., Wali, S., et al. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.02.012 · Cited by 11
Personalizing cholesterol treatment recommendations for primary cardiovascular disease prevention
Sarraju, A., Ward, A., Li, J., Valencia, A., Palaniappan, L. P., Scheinker, D., & Rodríguez, F. (2022) · Scientific Reports · doi:10.1038/s41598-021-03796-6 · Cited by 11
Impact of cardiologist intervention on guideline-directed use of statin therapy
Cassagnol, M., Hai, O. Y., Sherali, S. A., D’Angelo, K., Bass, D., Zeltser, R., & Makaryus, A. N. (2020) · World Journal of Cardiology · doi:10.4330/wjc.v12.i8.419 · Cited by 10
A Radiomics-Based Nomogram Using Ultrasound Carotid Plaque Evaluation For Predicting Cerebro-Cardiovascular Events In Asymptomatic Patients
Huang, Z., Cheng, X.-Q., Lu, R.-R., Gao, Y., Lv, W., Liu, K., Liu, Y., Xiong, L., Bi, X.-J., & Deng, Y. (2024) · Academic Radiology · doi:10.1016/j.acra.2024.05.030 · Cited by 10
Quality Improvement and Personalization for Statins: the QUIPS Quality Improvement Randomized Trial of Veterans’ Primary Care Statin Use
Sussman, J. B., Holleman, R. G., Youles, B., & Lowery, J. C. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4681-6 · Cited by 10
Moderate-Intensity Statins Plus Ezetimibe vs. High-Intensity Statins After Coronary Revascularization: A Cohort Study
Kim, J., Kang, D., Park, H., Kang, M., Choi, K. H., Park, T. K., Lee, J. M., Yang, J. H., Song, Y. B., Choi, J., et al. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07256-1 · Cited by 9
Guideline‐directed statin intensification in patients with new or worsening symptoms of peripheral artery disease
Khariton, Y., Patel, K., Chan, P. S., Pokharel, Y., Wang, J., Spertus, J. A., Safley, D. M., Hiatt, W. R., & Smolderen, K. G. E. (2018) · Clinical Cardiology · doi:10.1002/clc.23087 · Cited by 9
Self-citation
Guidelines impact cholesterol management
Yu, S., Zolfaghari, K., Rascati, K. L., Copeland, L. A., Godley, P. J., & McNeal, C. J. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.03.002 · Cited by 8
Trends in high-intensity statin use and low-density lipoprotein cholesterol control among patients enrolled in a clinical pharmacy cardiac risk service
Lamprecht, D. G., Shaw, P. B., King, J. B., Hogan, K. N., & Olson, K. L. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.04.007 · Cited by 9
The Pooled Cohort Equations and the Test of Time
Lloyd‐Jones, D. M. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.024 · Cited by 8
How to Use Quasi-Experimental Methods in Cardiovascular Research: A Review of Current Practice
Carter, A. W., Jayawardana, S., Costa‐Font, J., Nasir, K., Krumholz, H. M., & Mossialos, E. A. (2024) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.123.010078 · Cited by 9
Self-citation
Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease—Perspective from the Veterans Affair Healthcare System
Jia, X., Lee, M., Ramsey, D. J., Rifai, M. A., Mahtta, D., Krittanawong, C., Akeroyd, J. M., Matheny, M. E., Gobbel, G. T., Stone, N. J., et al. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07148-4 · Cited by 7
Self-citation
Statin Eligibility and Prescribing Across Racial, Ethnic, and Language Groups over the 2013 ACC/AHA Guideline Change: a Retrospective Cohort Analysis from 2009 to 2018
Heintzman, J. D., Kaufmann, J., Rodríguez, C. J., Lucas, J., Boston, D., April-Sanders, A., Chung‐Bridges, K., & Marino, M. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08139-x · Cited by 8
Cultural primer for cardiometabolic health: health disparities, structural factors, community, pathways to improvement, and clinical applications
KONES, R. J., & Rumana, U. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1421395 · Cited by 7
The Impact of Novel Reconstruction Algorithms on Calcium Scoring: Results on a Dedicated Cardiac CT Scanner
Vecsey-Nagy, M., Jokkel, Z., Jermendy, Á. L., Nagy, M. G., Boussoussou, M., Vattay, B., Kolossváry, M., Csobay-Novák, C., Amin-Spector, S., Merkely, B. P., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13040789 · Cited by 6
High-Intensity Statins
Laing, S. T. (2017) · JAMA · doi:10.1001/jama.2017.5781 · Cited by 6
A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents?
Maitra, N. S., Mahtta, D., Navaneethan, S. D., Vaughan, E. M., Kochar, A., Gulati, M., Levine, G. N., Petersen, L. A., & Virani, S. S. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01694-5 · Cited by 7
Self-citation
Diabetes is a cardiovascular disease, isn’t it?
Giugliano, D., Maiorino, M. I., Bellastella, G., & Esposito, K. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.11.006 · Cited by 6
HTE 3.0: Knowledge‐based systems in cascade for familial hypercholesterolemia detection and dyslipidemia treatment
López, B., Torrent‐Fontbona, F., Masana, L., & Zamora, A. (2021) · Expert Systems · doi:10.1111/exsy.12835 · Cited by 5
Risk Reduction to Disease Management: Clinical Pharmacists as Cardiovascular Care Providers
Palo, K. E. D., Patel, K., & Kish, T. D. (2018) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2018.07.003 · Cited by 5
Critical review of 2016 ACC guidelines on therapies for cholesterol lowering with reference to laboratory testing
Levinson, S. S. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.001 · Cited by 5
Statins and kidney health: exploring cardiovascular benefits, renal protection, and risks in chronic kidney disease
Chikatimalla, R., Trivedi, Y., Ruhela, N., Singh, S., Lal, A., Pawa, A., Singh, B., & Jain, R. (2025) · Postgraduate medicine · doi:10.1080/00325481.2025.2548199 · Cited by 4
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Bertolet, B. D., Cabral, K. P., Sullenberger, L. E., McAlister, J., Sandroni, T., & Patel, D. S. (2024) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-024-00665-1 · Cited by 4
A Cohort Analysis of Statin Treatment Patterns Among Small-Sized Primary Care Practices
Yu, J., Wang, A. A., Zimmerman, L. P., Deng, Y., Vu, T.-H. T., Tedla, Y. G., Soulakis, N. D., Ahmad, F. S., & Kho, A. N. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07191-9 · Cited by 4
Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines
Levintow, S. N., Reading, S. R., Saul, B., Yu, Y., Reams, D., McGrath, L. J., Philip, K. J., Dluzniewski, P. J., & Brookhart, M. A. (2020) · Clinical Epidemiology · doi:10.2147/clep.s259757 · Cited by 3
Utilization of High-Intensity Statins in Patients at Risk for Cardiovascular Events: A National Cross-Sectional Study
Moorman, J. M., Boyle, J., Bruno, L., Dugan, S. E., Everly, L., Gustafson, K. A., Hartzler, C., Homan, N., Joshi, D., King, C. A., et al. (2020) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001274 · Cited by 3
Prevalence, Clustering, and Current Management of Cardiovascular Risk Factors Upon First Referral to Hypertension Specialists: the APPROACH Study
Pinto, R. D., Rosei, C. A., Guardo, A. D., Giannattasio, C., Izzo, R., Mazza, A., Pucci, G., Sarzani, R., Tocci, G., Veglio, F., et al. (2024) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-024-00650-4 · Cited by 4
Dyslipidemia
Feldman, H. A., Zuber, K., & Davis, J. S. (2017) · Physician Assistant Clinics · doi:10.1016/j.cpha.2017.06.004 · Cited by 3
Life‐Saving Medications: The Urgent Need for Guideline Adherence and Patient Acceptance
Braun, L. T. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012348 · Cited by 3
US Public Health Gains from Improved Treatment of Hypercholesterolemia: A Simulation Study of NHANES Adults Treated to Guideline-Directed Therapy
Alexander, G. C., Curran, J. N., Victores, A., Mehta, H. B., Lin, S., Xiao, X., Michos, E. D., Ballreich, J. M., Bash, L. D., Exter, J., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09625-0 · Cited by 2
Correlation Between Atherosclerotic Cardiovascular Disease Risk Factors and Statin Prescribing Patterns.
Ahmed, F., Gross, S., Hammad, S., Wilson, C., Nawas, G. T., & Zeini, B. (2021) · PubMed Central · Cited by 2
Low-dose aspirin for primary prevention of cardiovascular disease: Trends in use patterns among African American adults in Minnesota, 2015–2019
Hof, J. V., Duval, S., Oldenburg, N. C., Misialek, J. R., Eder, M., Jones, C., Finnegan, J. R., & Luepker, R. V. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106589 · Cited by 1
Enhanced CT imaging artificial neural network coronary artery calcification score assisted diagnosis
Wang, Z., Zhu, D., Hu, G., & Shi, X. (2024) · Technology and Health Care · doi:10.3233/thc-231273 · Cited by 1
Potential impact of blood cholesterol guidelines on statin treatment in the U.S. population using interrupted time series analysis
Yew, P. Y., Loth, M., Adam, T. J., Wolfson, J. A., Liang, Y., Tonellato, P. J., & Chi, C. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03921-z · Cited by 1
Coronary Artery Calcium Detection with Dual-Energy Posteroanterior and Lateral Chest Radiography: Imaging Clues and Added Value of the Lateral View
Boswell, G. E., Drenckhahn, J. T., Bahorik, E. P., Greene, H. L., & Wolfgramm, S. (2025) · Radiology Cardiothoracic Imaging · doi:10.1148/ryct.240255 · Cited by 1
Comparison of rosuvastatin 10 mg plus ezetimibe versus rosuvastatin 20 mg in atherosclerotic cardiovascular disease and type 2 diabetes
Choi, H., Oh, S. J., Jo, Y. H., Park, Y. H., Park, Y. H., Yang, T., Doh, J., Hong, Y. J., Ahn, K. T., Cho, J. M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-00298-7 · Cited by 2
A simplified approach for prediction of stroke risk in asymptomatic carotid atherosclerosis
Huang, Z., Cheng, X.-Q., Liu, K., Xiong, L., Bi, X., & Deng, Y. (2025) · Acta Radiologica · doi:10.1177/02841851251345724 · Cited by 1
Pharmacists as Integral Members of the Cardiovascular Team
Dixon, D. L., Salgado, T. M., & Abbate, A. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.2795 · Cited by 1
Specialty preference for cardiovascular prevention practice in the Southeast US and role of a preventive cardiologist
Ponir, C., Seals, A. L., Caldarera, T., Ip, E. H., German, C. A., Taylor, Y. J., Moore, J. B., Bosworth, H. B., Shapiro, M. D., & Pokharel, Y. (2023) · Postgraduate Medical Journal · doi:10.1093/postmj/qgad082 · Cited by 1
Self-citation
Clinicians' self-reported Efficacy in Cardiovascular Prevention Practice in the Southeastern United States
Caldarera, T., Ponir, C., Seals, A. L., Penmetsa, M., Ip, E. H., German, C. A., Virani, S. S., Saha, A., Bosworth, H. B., Moore, J. B., et al. (2023) · Future Cardiology · doi:10.2217/fca-2023-0040 · Cited by 1
Self-citation
Breaking the Barriers in Resident Education: A Quality Improvement Initiative
Cabarga, L. H., Cubeddu, L. X., Olickal, J., Habibnejad, S., Kury-Perez, E., Pundhir, P., Pirela, D., & Goldszer, R. C. (2017) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000111 · Cited by 1
Generating Practice-Based Evidence in the Use of Guideline-Recommended Combination Therapy for Secondary Prevention of Acute Myocardial Infarction
Schroeder, M. C., Chapman, C. G., Chrischilles, E. A., Wilwert, J. M., Schneider, K. M., Robinson, J. G., & Brooks, J. M. (2022) · Pharmacy · doi:10.3390/pharmacy10060147 · Cited by 2
The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events trial: To continue or not? How to answer the question
Moffatt, S. D., D’Amico, T. A., Weisel, R. D., & Sade, R. M. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.09.066
Deep learning in cardiovascular imaging
Zeleznik, R. (2021) · doi:10.26481/dis.20210916rz
Efficacy and safety of PDE5 inhibitors in the treatment of diabetes mellitus erectile dysfunction: a systematic review and meta-analysisPreprint
Li, X., Zhao, Q., Wang, J., Wang, J., Dai, H., Li, Y., Chen, F., Wang, B., & Li, H. (2019) · Research Square · doi:10.21203/rs.2.10685/v1
Discussion
(2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.05.125

Authors: Pokharel, Y., Tang, F., Jones, P. G., Nambi, V., Bittner, V. A., Hira, R. S., Nasir, K., Chan, P. S., Maddox, T. M., Oetgen, W. J., Heidenreich, P. A., Borden, W. B., Spertus, J. A., Petersen, L. A., Ballantyne, C. M., & Virani, S. S.
Affiliations: Saint Luke's Hospital (US)
Department of Cardiovascular Research, Saint Luke’s Mid-America Heart Institute, Kansas City, Missouri
Houston Methodist (US)
University of Alabama at Birmingham (US)
University of Washington (US)
Center for Prevention and Wellness Research, Miami Beach, Florida
Denver VA Medical Center (US)
American College of Cardiology (US)
Stanford Medicine (US)
George Washington University (US)
Michael E. DeBakey VA Medical Center (US)
Baylor College of Medicine (US)
Corresponding author: Virani, Salim S.
ORCID: Pokharel, Yashashwi
Jones, Philip G.
Nambi, Vijay
Bittner, Vera A.
Hira, Ravi S.
Nasir, Khurram
Chan, Paul S.
Maddox, Thomas M.
Oetgen, William J.
Heidenreich, Paul A.
Borden, William B.
Spertus, John A.
Petersen, Laura A.
Ballantyne, Christie M.
Virani, Salim S.
Venue: JAMA Cardiology
Publisher: American Medical Association (AMA)
Published: 2017-04-01
Volume: 2
Issue: 4
Pages: 361
ISSN: 2380-6583 (ISSN-L)
DOI: 10.1001/jamacardio.2016.5922
PMC: PMC5470413
OpenAlex: W2592054892
Cited by: 107
References: 31
Citations by year: 2026: 2 · 2025: 7 · 2024: 9 · 2023: 11 · 2022: 10 · 2021: 12 · 2020: 11 · 2019: 16 · 2018: 14 · 2017: 15
FWCI: 15.69
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: JAMA Cardiology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
eCommons - AKU (Aga Khan University) (submittedVersion)
Funders: National Heart, Lung, and Blood Institute (R01HL123980, T32HL110837)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Keywords: guideline adoption, statin therapy, non-statin lipid-lowering therapy, atherosclerotic cardiovascular disease, cardiovascular risk groups, cardiology practice, guideline implementation, cholesterol management, prescribing trends, cardiovascular disease prevention, hypercholesterolemia, dyslipidemia
MeSH terms: Aged, American Heart Association, Cardiology, Cardiovascular Diseases, Cholesterol, Female, Humans, Male, Registries, Retrospective Studies, United States, Biomarkers, Incidence, Practice Guidelines as Topic, Risk Assessment, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Disease Management, Guideline Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks